| Structure |
Chemical Name |
CAS |
MF |
 |
Olaparib Impurity 34 |
2795135-26-9 |
|
 |
Tofacitinib Impurity 86 |
|
|
 |
Metronidazole Impurity 2 |
|
|
 |
Erlotinib Impurity 56 |
|
|
 |
Voriconazole Impurity 20 |
|
|
![5-[ビス(2-クロロエチル)アミノ]-1-メチル-1H-ベンズイミダゾール-2-ブタン酸メチルエステル](/CAS/GIF/109882-25-9.gif) |
5-[ビス(2-クロロエチル)アミノ]-1-メチル-1H-ベンズイミダゾール-2-ブタン酸メチルエステル |
109882-25-9 |
C17H23Cl2N3O2 |
 |
Brivaracetam Impurity 33 |
|
|
 |
2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one |
1367369-77-4 |
C12H15N5O3 |
 |
Pyridoxine Impurity 12 |
58947-70-9 |
C8H9NO3 |
 |
(1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran- 2-yl)ethyl)-3,7-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl 2,2-dimethylbutanoate |
|
|
![Acetamide, N-[9-[[2-(acetyloxy)-1-(hydroxymethyl)ethoxy]methyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]-](/CAS/20200611/GIF/298197-26-9.gif) |
Acetamide, N-[9-[[2-(acetyloxy)-1-(hydroxymethyl)ethoxy]methyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]- |
298197-26-9 |
C13 H17 N5 O6 |
 |
Isatin indicator solution |
|
C8H5NO2 |
 |
Afatinib Impurity 74 |
1259015-90-1 |
C7H13NO2 |
 |
Parecoxib Impurity B |
|
|
 |
ナトリウム1-メチル-1H-テトラゾール-5-チオラート |
51138-06-8 |
C2H3N4NaS |
 |
Levofloxacin Impurity 5 |
2206360-62-3 |
C13H10FNO5 |
 |
Bisoprolol Impurity 37 |
|
|
![3-(4,6-diamino-5-((methoxycarbonyl)amino)pyrimidin-2-yl)-5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine 7-oxide](/) |
3-(4,6-diamino-5-((methoxycarbonyl)amino)pyrimidin-2-yl)-5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine 7-oxide |
|
|
 |
Nirmatrelvir Impurity 11 |
|
|
 |
3,5-ジヨード-4-(4-ヒドロキシ-3,5-ジヨードフェノキシ)安息香酸 |
2055-97-2 |
C13H6I4O4 |
![ethyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate](/CAS/20180702/GIF/625115-53-9.gif) |
ethyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate |
625115-53-9 |
C21H21FN8O2 |
 |
2-(ジメチルアミノ)-N-(2,6-ジメチルフェニル)アセトアミド |
21236-54-4 |
C12H18N2O |
 |
Axitinib Impurity a |
1347304-18-0 |
C22H18N4O2S |
 |
Teneligliptin Impurity 14 |
|
|
 |
Posaconazole Impurity 26 |
|
|
 |
Anastrozole IMpurity (3-(1-Cyano-1-Methylethyl)-alfa,alfa-diMethyl-5-(1H-,1,2,4-triazole-1-ylMethyl)-benzeneacetaMide) |
120512-03-0 |
C17H21N5O |
![3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile](/CAS/20211123/GIF/2374700-40-8.gif) |
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile |
2374700-40-8 |
C16H20N6O |
 |
Terbutaline Impurity |
52144-90-8 |
C26H29NO3 |
 |
Tofacitinib Impurity 70 |
|
|
 |
Sugammadex sodium Decomposition process Impurity 1 |
|
|
 |
NIMODIPINE RELATED COMPOUND B (2,6-ジメチル-4-(3-ニトロフェニル)-1,4-ジヒドロピリジン-3,5-ジカルボン酸ビス(2-メトキシエチル)) |
70172-96-2 |
C21H26N2O8 |
 |
(S)-4,6,7,11-tetrahydroxy-9-(2-hydroxyacetyl)-7,8-dihydrotetracene-5,12-dione |
|
|
 |
Fludarabine EP impurity K |
|
|
 |
Propene-13C |
20626-62-4 |
|
 |
(2R,5S)-5-(3,4-Dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2-carboxylic Acid (1R,2S,5R)-5-Methyl-2-(1-methylethyl)cyclohexyl Ester |
389128-28-3 |
C18H26N2O5S |
 |
Perospirone Impurity 11 |
|
|
![3-Thiophenecarboxylic acid, 4-methyl-5-(4-nitrophenyl)-2-[(propoxycarbonyl)amino]-, ethyl ester](/CAS/20210305/GIF/2591260-03-4.gif) |
3-Thiophenecarboxylic acid, 4-methyl-5-(4-nitrophenyl)-2-[(propoxycarbonyl)amino]-, ethyl ester |
2591260-03-4 |
C18H20N2O6S |
 |
Dolutegravir Impurity 7 |
2244161-71-3 |
C20H21N3O5 |
 |
Ampicillin Impurity A |
|
|
 |
Linagliptin iMpurity G |
668270-11-9 |
C25H28N8O2 |
 |
Apixaban Impurity 22 |
1449510-64-8 |
C25H26ClN5O4 |
 |
Mizolastine impurity C |
|
|
 |
ethyl 2-(3-cyano-4-propoxyphenyl)-4-methylthiazole-5-
carboxylate |
|
C17H18N2O3S |
 |
1-エチル-3-カルボキシ-6-フルオロ-1,4-ジヒドロ-7-(4-メチルピペラジノ)-4-オキソキノリン1-オキシド |
85145-21-7 |
C17H20FN3O4 |
 |
Vonoprazan Impurity 20 |
|
|
 |
Amlodipine Impurity 30 |
95574-97-3 |
C4H7ClO3 |
 |
Etoricoxib IMpurity |
1350206-14-2 |
C18H16N2O2S |
![N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-2-chloro-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine](/CAS/20130318/GIF/CB72601888.gif) |
N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-2-chloro-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
923036-25-3 |
C20H24ClN5 |
 |
Alogliptin Imp.13 |
|
|
 |
Olodaterol Impurity 24 |
|
|
 |
dimethyl 2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarb oxylate |
21829-09-4 |
C17H18N2O6 |
 |
HHUBRUYPYDODRB-UHFFFAOYSA-N |
106860-70-2 |
C8H5NO5 |
 |
methyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate |
|
C17H15NO4S |
 |
(3S.4S.5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-yl acetate |
3041980-36-0 |
C14H15F5O3 |
 |
Clopidogrel IMpurity 4 |
801319-16-4 |
C15H14ClNO2S |
 |
1,3-Dioxane-4-aceticacid,6-(cyanomethyl)-2,2-dimethyl-,(4R,6R)-(9CI) |
807312-27-2 |
C10H15NO4 |
 |
Benzoic acid, 2-chloro-4-nitro-, 2-(diethylamino)ethyl ester |
10367-96-1 |
C13H17ClN2O4 |
 |
(3R,5S)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid |
|
C33H35FN2O5 |
 |
Regorafenib Impurity MJ |
|
|
 |
Aztreonam Amide |
1219444-93-5 |
C13H20N6O8S2 |
 |
EMtricitabine iMpurity B |
|
|
 |
Tenofovirdisoproxil Impurity C |
1878175-82-6 |
C11H17N5O2 |
 |
Fondaparinux sodium impurity 6 |
|
|
 |
Terbutaline IMpurity B |
94120-05-5 |
C13H19NO3 |
![Benzonitrile, 2-[(4-chloro-3,6-dihydro-2,6-dioxo-1(2H)-pyrimidinyl)methyl]-](/CAS/20210305/GIF/2749357-07-9.gif) |
Benzonitrile, 2-[(4-chloro-3,6-dihydro-2,6-dioxo-1(2H)-pyrimidinyl)methyl]- |
2749357-07-9 |
C12H8ClN3O2 |
 |
Azilsartan medoxomil impurity261 |
2514957-39-0 |
C16H16FN3O4 |
 |
Deferasirox iMpurity |
1688656-83-8 |
C42H28N6O8S |
 |
Tenofovir Impurity 71 |
|
|
 |
Phenylephrine Impurity 1 |
|
C9H13NO2 |
![6-(1-Cyclopropyl-1H-pyrazol-4-yl)-3-[difluoro(6-fluoro-2H-indazol-5-yl)methyl]-1,2,4-triazolo[4,3-b]pyridazine](/CAS/20210305/GIF/1440964-95-3.gif) |
6-(1-Cyclopropyl-1H-pyrazol-4-yl)-3-[difluoro(6-fluoro-2H-indazol-5-yl)methyl]-1,2,4-triazolo[4,3-b]pyridazine |
1440964-95-3 |
C19H13F3N8 |
 |
Olprinone Impurity B |
|
|
 |
SiMvastatin 4'-Methyl Ether |
864357-88-0 |
C26H40O5 |
 |
3-(2-(cyclopent-3-en-1-yl)-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide |
|
|
 |
Fimasartan Impurity |
|
|
 |
Afatinib impurity 43 |
|
|
 |
Avanafil IMpurity 7 |
|
|
 |
4-Methoxy-a-methyl-L-phenylalanine |
65555-88-6 |
C11H15NO3 |
 |
Cistracurium Besylate EP Impurity D |
1075726-88-3 |
C31H39NO9S |
 |
4-((4-メチルピペラジン-1-イル)メチル)-3-(トリフルオロメチル)安息香酸 |
859282-11-4 |
C14H17F3N2O2 |
![Benzoic acid, 4-[(2S,4S)-4-hydroxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidinyl]-](/CAS/20240320/GIF/1644670-02-9.gif) |
Benzoic acid, 4-[(2S,4S)-4-hydroxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidinyl]- |
1644670-02-9 |
C23H26N2O4 |
 |
methyl (Z)-3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
|
C24H21N3O3 |
 |
Oseltamivir Impurity 53 |
|
|
 |
Linagliptin impurity KH-3 |
2279114-27-9 |
C30H37N7O6 |
 |
Cilastatin Impurity 8 |
|
|
 |
isopropyl 2-(2-oxopyrrolidin-1-yl)acetate |
1249080-59-8 |
C9H15NO3 |
 |
(E)-2-(7-methoxy-3,4-dihydronaphthalen-1(2H)-ylidene)ethan-1-amine |
1371535-54-4 |
C13H17NO |
 |
Ticagrelor Impurity 129 |
1381841-36-6 |
C15H19NO3 |
![(9R,12S,13R,14S,17R,18E,21S,23S,24R,25R,27R)-1,14,24-トリヒドロキシ-12-[(1Z)-1-[(1R,3R,4R)-4-ヒドロキシ-3-メトキシシクロヘキシル]プロパ-1-エン-2-イル]-23-メトキシ-13,19,21,27-テトラメチル-17-(プロパ-2-エン-1-イル)-11,28-ジオキサ-4-アザトリシクロ[23.2.1.04,9]オクタコサ-18-エン-2,3,10,16-テトラオン](/CAS/20210111/GIF/132172-14-6.gif) |
(9R,12S,13R,14S,17R,18E,21S,23S,24R,25R,27R)-1,14,24-トリヒドロキシ-12-[(1Z)-1-[(1R,3R,4R)-4-ヒドロキシ-3-メトキシシクロヘキシル]プロパ-1-エン-2-イル]-23-メトキシ-13,19,21,27-テトラメチル-17-(プロパ-2-エン-1-イル)-11,28-ジオキサ-4-アザトリシクロ[23.2.1.04,9]オクタコサ-18-エン-2,3,10,16-テトラオン |
132172-14-6 |
C43H67NO12 |
 |
Cisatracurium besylate impurity 20 |
96946-54-2 |
C59H77N2O15S+ |
 |
4-ヒドロキシ-2-メチル-3-メトキシカルボニル-2H-1,2-ベンゾチアジン1,1-ジオキシド |
35511-15-0 |
C11H11NO5S |
 |
(2R)-N-(2,6-DIMETHYLPHENYL)-2-PIPERIDINECARBOXAMIDE |
27262-43-7 |
C14H20N2O |
 |
(Z)-methyl 3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
1987887-92-2 |
C24H21N3O3 |
 |
RAC デヒドロ-O-デスメチルベンラファキシン |
1346600-38-1 |
C16H23NO |
 |
Apremilast Impurity 6 |
|
|
 |
1-メチル-2-フェノキシエチルアミン |
35205-54-0 |
C9H13NO |
 |
Rosuvastatin Impurity 153 |
|
|
 |
CEFMETAZOLE IMPURITY |
76952-82-4 |
C13H16N6O5S3 |
 |
Vildagliptin impurity E |
|
|
 |
Carbazochrome Sodium Sulfonate Impurity 4 |
|
|
![D-Phenylalanine, N-[(1,1-diMethylethoxy)carbonyl]-L-leucyl-, Methyl ester](/CAS/20150408/GIF/15136-32-0.gif) |
D-Phenylalanine, N-[(1,1-diMethylethoxy)carbonyl]-L-leucyl-, Methyl ester |
15136-32-0 |
C21H32N2O5 |